Ardelyx Inc (ARDX)
9.02
-0.26
(-2.80%)
USD |
NASDAQ |
May 08, 11:03
Ardelyx Market Cap: 2.110B for May 8, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 07, 2024 | 2.171B |
| May 06, 2024 | 2.141B |
| May 03, 2024 | 2.040B |
| May 02, 2024 | 1.589B |
| May 01, 2024 | 1.547B |
| April 30, 2024 | 1.497B |
| April 29, 2024 | 1.511B |
| April 26, 2024 | 1.502B |
| April 25, 2024 | 1.476B |
| April 24, 2024 | 1.504B |
| April 23, 2024 | 1.495B |
| April 22, 2024 | 1.523B |
| April 19, 2024 | 1.516B |
| April 18, 2024 | 1.507B |
| April 17, 2024 | 1.533B |
| April 16, 2024 | 1.570B |
| April 15, 2024 | 1.591B |
| April 12, 2024 | 1.652B |
| April 11, 2024 | 1.724B |
| April 10, 2024 | 1.668B |
| April 09, 2024 | 1.677B |
| April 08, 2024 | 1.713B |
| April 05, 2024 | 1.755B |
| April 04, 2024 | 1.675B |
| April 03, 2024 | 1.720B |
| Date | Value |
|---|---|
| April 02, 2024 | 1.717B |
| April 01, 2024 | 1.734B |
| March 28, 2024 | 1.699B |
| March 27, 2024 | 1.724B |
| March 26, 2024 | 1.727B |
| March 25, 2024 | 1.792B |
| March 22, 2024 | 1.792B |
| March 21, 2024 | 1.822B |
| March 20, 2024 | 1.815B |
| March 19, 2024 | 1.866B |
| March 18, 2024 | 1.824B |
| March 15, 2024 | 1.885B |
| March 14, 2024 | 1.868B |
| March 13, 2024 | 2.010B |
| March 12, 2024 | 1.959B |
| March 11, 2024 | 1.976B |
| March 08, 2024 | 2.022B |
| March 07, 2024 | 2.087B |
| March 06, 2024 | 2.217B |
| March 05, 2024 | 2.231B |
| March 04, 2024 | 2.103B |
| March 01, 2024 | 2.173B |
| February 29, 2024 | 2.169B |
| February 28, 2024 | 2.201B |
| February 27, 2024 | 2.250B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
73.76M
Minimum
Jun 14 2022
2.264B
Maximum
Feb 09 2024
581.76M
Average
550.70M
Median
Market Cap Benchmarks
| Nektar Therapeutics | 283.69M |
| Rigel Pharmaceuticals Inc | 182.39M |
| Omeros Corp | 209.17M |
| Vistagen Therapeutics Inc | 124.86M |
| Karyopharm Therapeutics Inc | 130.60M |
Market Cap Related Metrics
| PS Ratio | 12.87 |
| Price to Book Value | 13.99 |
| Price | 9.02 |
| Earnings Yield | -3.22% |